There is emerging evidence suggesting that AD is fundamentally a metabolic disease and brain glucose utilization and responsiveness to IGF stimulation may play key roles behind neuronal loss, loss of synaptic connections, tau hyperphosphorylation, and Aβ accumulation [267]. Here, MAPT is linked to Alzheimer disease.